Skip to main content

Table 3 Responses to neoadjuvant therapy

From: Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study

Response to

neoadjuvant therapy

Group 1

(n = 19)

Group 2

(n = 40)

P value

ORR

17(89.5)

18(45)

< 0.001

cCR, n (%)

2 (10.5)

0

 

cPR, n (%)

15 (78.9)

18 (45.0)

 

cSD, n (%)

2 (10.5)

20 (50.0)

 

cPD, n (%)

0

2 (5.0)

 
  1. ORR, objective response rate; cCR, clinical complete response; cPR, clinical partial response; cSD, clinical stable disease; cPD, clinical progressive disease
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us